379 related articles for article (PubMed ID: 27640031)
1. Patient selection for TAVI in 2016: should we break through the low-risk barrier?
Abdelghani M; Serruys PW
EuroIntervention; 2016 Sep; 12(Y):Y46-50. PubMed ID: 27640031
[TBL] [Abstract][Full Text] [Related]
2. Upcoming TAVI trials: rationale, design and impact on clinical practice.
Capodanno D; Leon MB
EuroIntervention; 2016 Sep; 12(Y):Y51-5. PubMed ID: 27640033
[TBL] [Abstract][Full Text] [Related]
3. What are the remaining limitations of TAVI?
De Biase C; Mastrokostopoulos A; Philippart R; Bonfils L; Berthoumieu P; Dumonteil N
J Cardiovasc Surg (Torino); 2018 Jun; 59(3):373-380. PubMed ID: 29557590
[TBL] [Abstract][Full Text] [Related]
4. Late degeneration of transcatheter aortic valves: pathogenesis and management.
Barbanti M; Tamburino C
EuroIntervention; 2016 Sep; 12(Y):Y33-6. PubMed ID: 27640028
[TBL] [Abstract][Full Text] [Related]
5. Transcatheter Versus Surgical Aortic Valve Replacement in Low-Surgical-Risk Patients: A Meta-Analysis of Randomized-Controlled Trials and Propensity-Matched Studies.
Rawasia WF; Usman MS; Mujeeb FA; Zafar M; Khan SU; Alkhouli M
Cardiovasc Revasc Med; 2020 May; 21(5):612-618. PubMed ID: 31672536
[TBL] [Abstract][Full Text] [Related]
6. Expanding the indications for transcatheter aortic valve implantation.
Rahhab Z; El Faquir N; Tchetche D; Delgado V; Kodali S; Mara Vollema E; Bax J; Leon MB; Van Mieghem NM
Nat Rev Cardiol; 2020 Feb; 17(2):75-84. PubMed ID: 31527743
[TBL] [Abstract][Full Text] [Related]
7. Comparison of late mortality after transcatheter aortic valve implantation versus surgical aortic valve replacement: Insights from a meta-analysis.
Ando T; Takagi H;
Eur J Intern Med; 2017 May; 40():43-49. PubMed ID: 28162851
[TBL] [Abstract][Full Text] [Related]
8. Transcatheter Valve Replacement: Risk Levels and Contemporary Outcomes.
Reyes M; Reardon MJ
Methodist Debakey Cardiovasc J; 2017; 13(3):126-131. PubMed ID: 29743997
[TBL] [Abstract][Full Text] [Related]
9. A paradigm shift from surgical to transcutaneous aortic valve replacement (PARTNER 3 and Evolut Low Risk trials).
Taggart DP
Cardiovasc Res; 2019 Sep; 115(11):e107-e108. PubMed ID: 31436831
[No Abstract] [Full Text] [Related]
10. When to SAVR in the age of TAVR? A perspective on surgical aortic valve replacement in 2018.
Wyler von Ballmoos MC; Barker CM; Reul RM; Dadu R; Ramchandani M; Kleiman NS; Reardon MJ
Cardiovasc Revasc Med; 2018 Mar; 19(2):139-141. PubMed ID: 29661491
[No Abstract] [Full Text] [Related]
11. [We carry out too many TAVI - contra].
Yücel S; Ince H; D'Ancona G; Kische S; Öner A
Herz; 2016 Mar; 41(2):102-10. PubMed ID: 26914581
[TBL] [Abstract][Full Text] [Related]
12. Conventional versus Transapical Aortic Valve Replacement: Is It Time for Shift in Indications?
Baumbach H; Ahad S; Rustenbach C; Hill S; Schäufele T; Wachter K; Franke UF
Thorac Cardiovasc Surg; 2017 Apr; 65(3):212-217. PubMed ID: 27517166
[No Abstract] [Full Text] [Related]
13. Transcatheter Aortic Valve Implantation in High-Risk/Inoperable Patients: Repositionable versus Non-Repositionable Self-Expanding Valve.
Veulemans V; Sötemann DB; Kleinebrecht L; Keymel S; Jung C; Zeus T; Kelm M; Westenfeld R
J Heart Valve Dis; 2017 Jul; 26(4):405-412. PubMed ID: 29302939
[TBL] [Abstract][Full Text] [Related]
14. Durability of prostheses for transcatheter aortic valve implantation.
Arsalan M; Walther T
Nat Rev Cardiol; 2016 Jun; 13(6):360-7. PubMed ID: 27053461
[TBL] [Abstract][Full Text] [Related]
15. The beginning of a new era in the field of percutaneous valvular interventions (PARTNER 3 and Evolut Low Risk trials).
Dudek D
Cardiovasc Res; 2019 Sep; 115(11):e105-e106. PubMed ID: 31436829
[No Abstract] [Full Text] [Related]
16. Aortic Valve Replacement: Are We Spoiled for Choice?
Bashir M; Harky A; Bleetman D; Adams B; Roberts N; Balmforth D; Yap J; Lall K; Shipolini A; Oo A; Uppal R
Semin Thorac Cardiovasc Surg; 2017 Autumn; 29(3):265-272. PubMed ID: 28935509
[TBL] [Abstract][Full Text] [Related]
17. Challenges for Expanded Use of Transcatheter Aortic Valve Replacement.
Pineda AM; Bass TA
Circ Cardiovasc Interv; 2017 Dec; 10(12):. PubMed ID: 29246922
[No Abstract] [Full Text] [Related]
18. Bioprosthetic aortic valve durability in the era of transcatheter aortic valve implantation.
Salaun E; Clavel MA; Rodés-Cabau J; Pibarot P
Heart; 2018 Aug; 104(16):1323-1332. PubMed ID: 29735584
[TBL] [Abstract][Full Text] [Related]
19. Transcutaneous aortic valve implantation using the carotid artery access: Feasibility and clinical outcomes.
Kallinikou Z; Berger A; Ruchat P; Khatchatourov G; Fleisch I; Korkodelovic B; Henchoz E; Marti RA; Cook S; Togni M; Goy JJ
Arch Cardiovasc Dis; 2017; 110(6-7):389-394. PubMed ID: 28433509
[TBL] [Abstract][Full Text] [Related]
20. [TAVI in Germany. What have we learned from current studies?].
Mader N; Rudolph T; Baldus S; Wahlers T
Herz; 2016 Mar; 41(2):97-101. PubMed ID: 26838062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
